News for 'Indian Healthcare'

'India Is Staring At Dementia Epidemic'

'India Is Staring At Dementia Epidemic'

Rediff.com21 Nov 2025

'10 million Indians are currently living with dementia, and the number is expected to double by 2036.'

India restores embassy in Kabul, vows to deepen ties with Afghanistan

India restores embassy in Kabul, vows to deepen ties with Afghanistan

Rediff.com21 Oct 2025

The MEA release said that the embassy of India in Kabul will further augment India's contribution to Afghanistan's comprehensive development.

Dream On... Viksit Bharat

Dream On... Viksit Bharat

Rediff.com27 Oct 2025

Can change happen? Not unless the changemakers themselves want it since they benefit the most from the status quo, warns Biswajit Dasgupta.

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Trump's 100% tariff on pharma unlikely to hurt domestic industry: Experts

Rediff.com26 Sep 2025

Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.

How India's pharma cos plan to tackle steep US tariffs

How India's pharma cos plan to tackle steep US tariffs

Rediff.com10 Sep 2025

As the potential threat of a steep 200 per cent tariff on pharmaceutical imports hangs in the air, analysts and industry insiders feel that focus on exports to non-US regions as well as domestic market will increase as a long-term trend. US President Donald Trump told CNBC's Squawk Box in the first week of August that planned tariffs on import of pharmaceutical products to the US could eventually reach up to 250 per cent.

'Next Samvat Could See Equities Align With Economic Growth'

'Next Samvat Could See Equities Align With Economic Growth'

Rediff.com16 Oct 2025

'The outlook for the next Samvat is more constructive, as many of the earlier drags are gradually becoming supports.'

Smallcaps Face Their Toughest Samvat Yet

Smallcaps Face Their Toughest Samvat Yet

Rediff.com18 Oct 2025

'Defence, capital goods, engineering, capital market-related stocks, autos, and cement sectors are my bullish bets for Samvat 2082.'

'BJP Isn't Undefeatable In North India, But...'

'BJP Isn't Undefeatable In North India, But...'

Rediff.com19 Nov 2025

'...the electoral playing field is tilted significantly in its favour.'

'On Track For GDP Growth Exceeding 6.8%'

'On Track For GDP Growth Exceeding 6.8%'

Rediff.com3 Nov 2025

'I will not be surprised if there is a 7 per cent handle in front of the decimal place for the full financial year.'

Cough Syrup For Kids: Centre Tightens Rules

Cough Syrup For Kids: Centre Tightens Rules

Rediff.com4 Oct 2025

Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan.

The New AI Career Map For India's Youth

The New AI Career Map For India's Youth

Rediff.com9 Oct 2025

AI is changing jobs in India faster than ever, but professionals are learning the real skill isn't coding -- it's adaptability.

Russia strikes Indian pharma warehouse in Ukraine

Russia strikes Indian pharma warehouse in Ukraine

Rediff.com13 Apr 2025

A Russian missile struck a warehouse belonging to an Indian pharmaceutical company, Kusum, in Ukraine, according to the Ukrainian embassy in India. The embassy alleged that Russia, despite claiming a "special friendship" with India, deliberately targeted Indian businesses in Ukraine. The strike reportedly destroyed medicines intended for children and the elderly. This incident follows a similar attack on a major pharmaceuticals warehouse in Kyiv, which was destroyed by Russian drones, as reported by the UK's ambassador to Ukraine. Kusum Healthcare, the company whose warehouse was hit, has a presence in 29 countries, including Ukraine. This attack comes amidst ongoing tensions in the region as Russia continues its offensive against Ukraine, despite US efforts to push for a ceasefire. Ukrainian Foreign Minister Andrii Sybiha accused Russia of being the sole obstacle to peace and claimed that Moscow rejected a US-brokered proposal for a ceasefire.

Ditch Quick-Money Lures This Diwali!

Ditch Quick-Money Lures This Diwali!

Rediff.com20 Oct 2025

: Build lasting wealth via disciplined, long-term mutual fund investing in India's compounding marathon, Shanaihi, Shanaihi, says Ramalingam Kalirajan

'We Aren't Security Conscious As A Nation'

'We Aren't Security Conscious As A Nation'

Rediff.com6 Nov 2025

'Government officials use Gmail and ordinary phones without basic security consciousness.' 'Interoperability, especially in joint exercises with countries like the US, worries me.' 'It often means we open our systems to them, but they don't reciprocate.' 'They could have kill switches in their systems and might even be able to affect ours.'

'No Such Thing As Diabetes Reversal'

'No Such Thing As Diabetes Reversal'

Rediff.com14 Nov 2025

'In diabetes remission, you go below a 6.5 HbA1c without medication.' 'And this happens only when you lose 10 to 15 per cent of your body weight with a good amount of lifestyle and dietary changes, exercise and sometimes medication.' 'You have to be able to sustain your HBA1C below 6.5 for at least a year without medication to say that the patient is in remission.'

Drugmakers look to fill Rs 600 cr Novo vacuum

Drugmakers look to fill Rs 600 cr Novo vacuum

Rediff.com25 Sep 2025

Indian drugmakers Eris Lifesciences, Wockhardt and Lupin are prepping to cash in when Danish company Novo Nordisk bows out of the human insulin pen market by the end of this year and creates an opportunity estimated to be worth Rs 600-800 crore in the domestic market. Some self-use disposable pens are pre-filled with insulin and others can be reused with new cartridges.

Indian healthcare appalling, but Tamil Nadu shines

Indian healthcare appalling, but Tamil Nadu shines

Rediff.com24 Dec 2009

The most important thing for India is to resurrect public health services in the country, says Shankar Acharya.

'India-US ties not criteria for New Delhi-Russia relations'

'India-US ties not criteria for New Delhi-Russia relations'

Rediff.com28 Sep 2025

Lavrov, who addressed the UN General Assembly shortly before External Affairs Minister S Jaishankar's speech at the high-level General Debate, said India and Russia share a "particularly privileged strategic partnership".

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

'Anxious' Indian students at Harvard stare at uncertainties

'Anxious' Indian students at Harvard stare at uncertainties

Rediff.com10 Jun 2025

Indian students at Harvard, on condition of anonymity, shared their concerns and experiences of the last few months during which the prestigious university has seen relentless attacks by the Trump administration.

Realty's Next Address: SPR, Sohna Power NCR's Growth

Realty's Next Address: SPR, Sohna Power NCR's Growth

Rediff.com18 Oct 2025

Part-I of this three-part series dives into Delhi-NCR's SPR, Sohna, Dwarka Expressway, and Jewar Airport leading the charge.

'Indians are bad': Florida nurse may lose eyesight after brutal attack

'Indians are bad': Florida nurse may lose eyesight after brutal attack

Rediff.com5 Mar 2025

A 67-year-old Indian-origin nurse, Leela Lal, was severely beaten by a patient at a Florida hospital, leaving her with multiple facial fractures and potentially losing her eyesight. Stephen Eric Scantlebury, the 33-year-old patient, allegedly made racially charged comments during the attack, leading to a hate crime enhancement in his charges. Lal's injuries are described as critical, with "essentially every bone in the victim's face" broken. Scantlebury remains jailed, with a judge ruling him a danger to the community.

34% Indians Face Job Stress; 49% Want To Change Jobs

34% Indians Face Job Stress; 49% Want To Change Jobs

Rediff.com5 May 2025

30% of Indian employees report experiencing daily stress in their workplace. This high stress level is compounded by anger, with 34% of Indian employees experiencing daily anger at work -- a figure significantly higher than many other countries.

Hospitals Boost IT Spend to Fight Cyber Threats

Hospitals Boost IT Spend to Fight Cyber Threats

Rediff.com20 Jun 2025

The growing caution among hospitals is being driven by a rise in double-extortion ransomware attacks, AI-enabled phishing, deepfake fraud, and vulnerabilities in connected medical devices.

Top Competitive Exams After Class 12

Top Competitive Exams After Class 12

Rediff.com18 Aug 2025

rediffGURU Nayagam PP, career counsellor and the founder of EduJob360, counsels students and aspiring professionals about how they can make the right career decision.

1 In 5 Super Rich Indians Plans To Move Abroad

1 In 5 Super Rich Indians Plans To Move Abroad

Rediff.com27 Mar 2025

These super-rich Indians intend to reside in their chosen host country permanently while retaining their Indian citizenship.

Amazon enters India's $15 bn diagnostics market with At-Home testing

Amazon enters India's $15 bn diagnostics market with At-Home testing

Rediff.com23 Jun 2025

Amazon India has launched Amazon Diagnostics, an at-home healthcare service that allows customers to book lab tests, schedule appointments and receive digital reports directly via the Amazon app. Initially available in six cities-Bengaluru, Delhi, Gurgaon, Noida, Mumbai and Hyderabad-the service covers more than 450 PIN codes and offers access to over 800 diagnostic tests.

Prez hails Op Sindoor, Atmanirbhar Bharat in I-Day address

Prez hails Op Sindoor, Atmanirbhar Bharat in I-Day address

Rediff.com15 Aug 2025

President Droupadi Murmu addressed the nation on the eve of Independence Day, praising the response to terrorism, highlighting achievements in defense self-reliance, and emphasizing unity and progress.

Dixon gets govt nod for JV with Chinese firm Longcheer

Dixon gets govt nod for JV with Chinese firm Longcheer

Rediff.com25 Jul 2025

Dixon Technologies has received approval from the Indian government to form a joint venture (JV) with Chinese peer Longcheer, according to a regulatory filing. The JV will be formed between Dixon and Longcheer's Singapore-based subsidiary.

'Indian Stocks Unlikely To Give Significant Returns In 12 Months'

'Indian Stocks Unlikely To Give Significant Returns In 12 Months'

Rediff.com30 May 2025

'Right now, silver -- and especially platinum -- are very cheap compared to gold. If I were buying today, I would choose platinum.'

Sitharaman asks fintechs to strengthen risk management to check AI misuse

Sitharaman asks fintechs to strengthen risk management to check AI misuse

Rediff.com8 Oct 2025

Finance Minister Nirmala Sitharaman on Tuesday asked fintech firms to focus on risk management at a time when criminals are using AI to mimic voices, clone identities and create lifelike videos to manipulate people.

Modi's Manipur outreach is part of 5-state visit

Modi's Manipur outreach is part of 5-state visit

Rediff.com12 Sep 2025

Prime Minister Narendra Modi is scheduled to visit Mizoram, Manipur, Assam, West Bengal, and Bihar to launch infrastructure projects, participate in Bhupen Hazarika's birth centenary, and attend the Combined Commanders' Conference.

Lace & Luxury: Mona Patel At The Bezos Wedding

Lace & Luxury: Mona Patel At The Bezos Wedding

Rediff.com27 Jun 2025

IndianAmerican entrepreneur and philanthropist Mona Patel joined the ultraglamorous guest list at JeffBezos and LaurenSnchez's lavish prewedding celebrations in Venice.

Australia Visa Changes: What Indian Students Must Know

Australia Visa Changes: What Indian Students Must Know

Rediff.com30 Apr 2025

Australia's new student visa rules focuses on stricter eligibility, higher financial and English language requirements among others.

Indian Pharma Gets Relief from Trump's Tariffs

Indian Pharma Gets Relief from Trump's Tariffs

Rediff.com4 Apr 2025

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages.

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Generic industry unlikely to be affected by Trump's EO: Indian drug cos

Rediff.com14 May 2025

A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies, while sparing the Indian generic drug makers in the short term. US President Donald Trump signed the EO on Monday, directing the US Trade Representative and the Secretary of Commerce to act against foreign countries that "purposefully and unfairly undercut market prices", driving price hikes in the US.

We can't do what China does: Rahul Gandhi in Colombia

We can't do what China does: Rahul Gandhi in Colombia

Rediff.com3 Oct 2025

Congress leader Rahul Gandhi has said the 'wholesale attack on the democratic system' currently underway in India is the single biggest risk the country is facing, and asserted that allowing different traditions to thrive is very important as 'we cannot do what China does, which is to run an authoritarian system'. IMAGE: Kindly note that this image has been posted for representational purposes only. Photograph: / Rediff.com Speaking at a seminar titled 'The Future is Today' at the EIA University in Medellin, Colombia, Gandhi also alleged that there are 'huge amounts of corruption at a centralised level' in India now. "In India, we have huge amounts of corruption now at a very centralised level. So, three or four businesses taking over the whole economy, having a direct relationship with the prime minister, is rampant in India," the Leader of Opposition in Lok Sabha said. "But I believe decentralising power, making things more transparent, bringing people into conversations, and bringing people into processes is the best way forward," Gandhi said while addressing the seminar on Wednesday. Hitting back at the Congress leader for his remarks, the Bharatiya Janata Party on Thursday accused Gandhi of insulting and degrading India on foreign soil. Posting a video clip of Gandhi's speech on X, BJP national spokesperson Gaurav Bhatia said, 'Rahul Gandhi does it again, degrades India on foreign soil. From defaming our democracy in London, to mocking our institutions in the US, now in Colombia he spares no chance to insult Bharat globally.' 'This isn't dissent. It's disgrace to the fake Gandhi. Criticising BJP may be your right but dare you malign Mother India for your cheap and petty politics,' Bhatia said. Speaking at the seminar, Gandhi said India has a much more complex system as compared to China and its strengths are very different from that of the neighbouring country. India also has a very old spiritual tradition and a thought system with profound ideas that are useful in today's world, he said, adding that there is a lot that the country can offer in terms of tradition and way of thinking. "I am very optimistic about India, but at the same time, there are fault lines within the Indian structure. There are risks that India has to overcome. The single-biggest risk is the attack on democracy that is taking place in India," the Leader of Opposition said. "India has multiple religions, traditions and languages. India is actually a conversation between all its people. Different ideas, religions and traditions require space. The best method for creating that space is the democratic system," he said. "Currently, there is a wholesale attack on the democratic system in India, so that is a risk. The other big risk is different conceptions -- some 16-17 different languages, different religions... So, allowing these different traditions to thrive, and giving them space to express themselves is very important for a country like India.

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Rediff.com12 Aug 2025

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Stock markets weather Trump tariff storm

Stock markets weather Trump tariff storm

Rediff.com7 Aug 2025

Among Sensex firms, Tech Mahindra, HCL Tech, Eternal, Axis Bank, Maruti, Tata Steel, HDFC Bank and Asian Paints were the gainers. However, Adani Ports, Trent, Tata Motors, Hindustan Unilever and NTPC were among the laggards.

India slams Pak on gross sexual violence against women

India slams Pak on gross sexual violence against women

Rediff.com20 Aug 2025

India has slammed Pakistan at a UN debate by drawing attention to the heinous crimes of gross sexual violence against women in erstwhile East Pakistan in 1971, adding the pattern continues with impunity to this day.